Concord Healthcare Group Co., Ltd. (HKG:2453)
Hong Kong
· Delayed Price · Currency is HKD 1.340
-0.010 (-0.75%)
Mar 10, 2026, 3:15 PM HKT
Concord Healthcare Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 370.22 | 388.31 | 538.65 | 472.17 | 470.51 | 166.32 |
| Revenue Growth (YoY) | -21.64% | -27.91% | 14.08% | 0.35% | 182.89% | - |
| Cost of Revenue | 402.57 | 455.57 | 603.71 | 614.77 | 517.62 | 158.43 |
| Gross Profit | -32.35 | -67.26 | -65.06 | -142.6 | -47.11 | 7.89 |
| Selling, General & Admin | 231.76 | 259.36 | 247.16 | 274 | 305.56 | 258.54 |
| Research & Development | 30.67 | 31.18 | 36.44 | 41.32 | 40.38 | 11.27 |
| Other Operating Expenses | -3.42 | -3.62 | -0.77 | -7.76 | 47 | 23.9 |
| Operating Expenses | 300.73 | 300.34 | 291.74 | 327.2 | 392.93 | 293.72 |
| Operating Income | -333.09 | -367.6 | -356.79 | -469.8 | -440.05 | -285.83 |
| Interest Expense | -121.9 | -109.27 | -108.01 | -274.48 | -435.31 | -323.47 |
| Interest & Investment Income | 0.47 | 0.73 | 7.28 | 7.79 | 5.47 | 5.99 |
| Earnings From Equity Investments | -2.17 | -1.31 | -1.74 | -0.22 | -0.16 | -0.07 |
| Currency Exchange Gain (Loss) | 0.17 | -1.09 | -0.04 | -0.64 | 0.56 | 1.65 |
| Other Non Operating Income (Expenses) | -83.99 | -66.15 | 26.8 | 41.68 | - | - |
| EBT Excluding Unusual Items | -540.51 | -544.69 | -432.49 | -695.67 | -869.49 | -601.73 |
| Gain (Loss) on Sale of Investments | 5.33 | 7.56 | - | - | - | - |
| Gain (Loss) on Sale of Assets | -0.94 | 40.07 | - | -1.13 | 29.89 | 1.63 |
| Asset Writedown | -0.39 | -0.54 | -0.25 | -0.77 | - | - |
| Other Unusual Items | 53.19 | 11.74 | 0.14 | 50.4 | 3.27 | 2.29 |
| Pretax Income | -483.32 | -485.85 | -432.59 | -647.17 | -836.34 | -597.81 |
| Income Tax Expense | -0.5 | -1.03 | -6.2 | -9.95 | -5.2 | -6.47 |
| Earnings From Continuing Operations | -482.82 | -484.82 | -426.39 | -637.22 | -831.13 | -591.34 |
| Minority Interest in Earnings | 44.88 | 41.6 | 53.3 | 95.82 | 14.54 | 8.08 |
| Net Income | -437.95 | -443.22 | -373.09 | -541.4 | -816.59 | -583.26 |
| Net Income to Common | -437.95 | -443.22 | -373.09 | -541.4 | -816.59 | -583.26 |
| Shares Outstanding (Basic) | 717 | 715 | 665 | 479 | - | - |
| Shares Outstanding (Diluted) | 717 | 715 | 665 | 479 | - | - |
| Shares Change (YoY) | 2.87% | 7.64% | 38.63% | - | - | - |
| EPS (Basic) | -0.61 | -0.62 | -0.56 | -1.13 | - | - |
| EPS (Diluted) | -0.61 | -0.62 | -0.56 | -1.13 | - | - |
| Free Cash Flow | -366.5 | -500.12 | 331.31 | -175.67 | -325.96 | -694.04 |
| Free Cash Flow Per Share | -0.51 | -0.70 | 0.50 | -0.37 | - | - |
| Gross Margin | -8.74% | -17.32% | -12.08% | -30.20% | -10.01% | 4.75% |
| Operating Margin | -89.97% | -94.67% | -66.24% | -99.50% | -93.53% | -171.85% |
| Profit Margin | -118.29% | -114.14% | -69.26% | -114.66% | -173.56% | -350.68% |
| Free Cash Flow Margin | -99.00% | -128.80% | 61.51% | -37.20% | -69.28% | -417.29% |
| EBITDA | -218.89 | -259.85 | -241.21 | -355.52 | -356.26 | -229.19 |
| EBITDA Margin | -59.13% | -66.92% | -44.78% | -75.29% | -75.72% | -137.80% |
| D&A For EBITDA | 114.19 | 107.75 | 115.58 | 114.29 | 83.79 | 56.64 |
| EBIT | -333.09 | -367.6 | -356.79 | -469.8 | -440.05 | -285.83 |
| EBIT Margin | -89.97% | -94.67% | -66.24% | -99.50% | -93.53% | -171.85% |
Source: S&P Capital IQ. Standard template. Financial Sources.